Citation Impact

Citing Papers

Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
Mindfulness-based cognitive therapy for inflammatory bowel disease patients: findings from an exploratory pilot randomised controlled trial
2015
A systematic review of evidence on the links between patient experience and clinical safety and effectiveness
2013 Standout
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
2016 Standout
Systematic review: impact of non‐adherence to 5‐aminosalicylic acid products on the frequency and cost of ulcerative colitis flares
2008
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
Adverse Health Effects of Marijuana Use
2014 Standout
The Chronic Gastrointestinal Consequences Associated With Campylobacter
2012
Ulcerative Colitis
2011 Standout
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Cytomegalovirus Infection in Patients with Active Inflammatory Bowel Disease
2010
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy
2015
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Crohn's disease
2012 Standout
New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives
2012
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
Epidemiology and risk factors for IBD
2015 Standout
Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches
2015
Factors Associated With Non-Adherence to Oral Medication for Inflammatory Bowel Disease: A Systematic Review
2009
Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: A prospective, multicenter study
2011
Ulcerative colitis
2012 Standout
Effect of intensive granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis positive for cytomegalovirus
2013
Crohn's disease
2016 Standout
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
2017
Impact of environmental and dietary factors on the course of inflammatory bowel disease
2012
Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohnʼs disease, while smoking decreases the risk of colectomy in ulcerative colitis
2010
Adsorptive Depletion of Myeloid Lineage Leucocytes as Remission Induction Therapy in Patients with Ulcerative Colitis after Failure of First-Line Medications: Results from a Three-Year Real World, Clinical Practice
2017
Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal
2009
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Ulcerative colitis
2016 Standout
Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
2008
Cytomegalovirus and ulcerative colitis: Place of antiviral therapy
2016
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
Periodontal diseases
2017 Standout
Ulcerative colitis
2020 Standout
Factors affecting outcomes in Crohn's disease over 15 years
2012
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Mucosal Healing in Crohnʼs Disease
2012
Management of Crohn's Disease in Adults
2009 Standout
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
Infliximab Treatment Does Not Induce Organ-specific or Nonorgan-specific Autoantibodies Other than Antinuclear and Anti-Double-Stranded DNA Autoantibodies in Crohnʼs Disease
2005
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Predatory and exploitative behaviour in academic publishing: An assessment
2019
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
2012
Visibility and Citation Impact
2014
Global Epidemiology of Campylobacter Infection
2015 Standout
Quality indicators for colonoscopy
2014 Standout
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis
2008
Web of Science (WoS) and Scopus: The Titans of Bibliographic Information in Today’s Academic World
2021 Standout
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
2015
Factors affecting number of citations: a comprehensive review of the literature
2016 Standout

Works of Isabel Bernal being referenced

Medication-Taking Behavior in a Cohort of Patients with Inflammatory Bowel Disease
2006
Development of antinuclear antibodies and its clinical impact in patients with Crohn's disease treated with chimeric monoclonal anti-TNFα antibodies (infliximab)
2003
Impact of azathioprine on the prevention of postoperative Crohnʼs disease recurrence: Results of a prospective, observational, long-term follow-up study
2008
Utilización de medicinas alternativas y consumo de drogas por pacientes con enfermedad inflamatoria intestinal
2007
Addition of Metronidazole to Azathioprine for the Prevention of Postoperative Recurrence of Crohn’s Disease
2013
Cytomegalovirus infection in ulcerative colitis: A prospective, comparative study on prevalence and diagnostic strategy
2008
Predictors of Clinical Response to Systemic Steroids in Active Ulcerative Colitis
2006
Prospective, Observational, Cross-Sectional Study of Intestinal Infections among Acutely Active Inflammatory Bowel Disease Patients
2009
OPRM: Challenges to Including Open Peer Review in Open Access Repositories
2017
Open Access and the Changing Landscape of Research Impact Indicators: New Roles for Repositories
2013
Rankless by CCL
2026